Increased use of hypnotics in individuals with celiac disease: a nationwide case-control study

BMC Gastroenterology

Table 3 Risk of poor sleep starting within 1 year before celiac disease diagnosis

	Celiac disease n = 2,933 (%)	Controls n = 14,571 (%)	Odds ratio	95% CI
Poor sleep ^a	126 (4.3)	471 (3.2)	1.35	1.10-1.65
Type of hypnotics used ^b
Benzodiazepine-related drugs	84 (2.9)	281 (1.9)	1.48	1.16-1.90
Benzodiazepines	5 (0.2)	35 (0.2)	0.71	0.28-1.79
Other hypnotics	7 (0.2)	56 (0.4)	0.63	0.29-1.37
Melatonin receptor agonists^c	0 (0.0)	1 (0.0)	-	-

Odds ratios estimated through conditional logistic regression modelling.
^aPoor sleep defined as ≥2 prescriptions of hypnotics before celiac disease diagnosis. Data capture of hypnotics: July 1st 2005-January 29th 2008.
^bSee Additional file 1: Table S1 for anatomical therapeutic chemical (ATC) codes used to classify hypnotics.
^cDue to lack of events no odds ratio was estimated.

ISSN: 1471-230X